Board effectiveness and CEO wellbeing.
A board effectiveness review measures composition, information flow, committee work, and oversight of the chief executive. It almost never measures the chief executive. CEREVITY gives boards a confidential clinical channel for the one person the whole system rests on.
Board effectiveness is how well a board governs: its composition, its information, its decision quality, and its oversight of the chief executive. Effectiveness reviews assess all of that and rarely ask whether the CEO is holding up. Boards close that gap by arranging confidential, private-pay therapy for the chief executive, held outside the company and outside the review.
What CEREVITY is.
A nationwide network of independent licensed clinicians, offered as a confidential benefit for the chief executive.
CEREVITY is a nationwide network of independent licensed clinicians providing private-pay therapy by secure telehealth across all 50 states. It is not an app, not a coaching marketplace, and not an employee assistance program. Each leader is matched by hand to a clinician experienced with high-responsibility roles, and keeps that clinician for as long as the work continues.
For a board, the mechanics are simple to reason about. Care is private pay with no insurance claim filed, so nothing routes through the company health plan and no claim record is created. The board authorizes the arrangement and never sees who uses it. There is no utilization report and no attendance data, because a channel the board can read is a channel the chief executive will not use.
Most boards arrive here from one of two directions. Some are building the leadership tier of a broader executive mental health benefit for companies and want the chair included rather than exempted. Others are already inside a succession process and have realized that the readiness of the incumbent is as material as the readiness of the bench.Why board effectiveness reviews miss this.
The review measures the board. It does not measure the condition of the person the board exists to oversee.
A board effectiveness review is a structured self-assessment, run annually in most large organizations. It covers composition and skills mix, meeting cadence and the quality of board materials, committee performance, boardroom dynamics, the working relationship with management, and succession. Every one of those categories describes a process. None of them describes whether the chief executive is sleeping, has anyone outside the company to think out loud with, or has quietly started planning an exit nobody has been told about. Directors carry their own version of the same load, which is why therapy for board members and directors exists as a separate practice.
The instrument is also thinner than its place on the governance calendar suggests, and the failure it is worst at anticipating is the one that costs the most: an unplanned departure at the top.
of corporate directors say their board's assessment process does not give a complete picture of how the board is performing. Nearly three quarters say their board runs no individual review at all. Source: PwC 2025 Annual Corporate Directors Survey, 638 corporate directors, published October 2025.
Two failure modes follow from the gap. In the first, a chief executive under sustained unmanaged strain performs to the floor of the role rather than its ceiling, and the board reads the shortfall as a capability problem and starts a search that was never necessary. In the second, the board learns the truth from a resignation letter, having had a year of quarterly meetings in which to notice. Both are versions of key person risk, and neither is visible in an effectiveness review, because the review does not ask.
The chief executive side of the picture is measurable. In a March 2024 survey of more than 3,000 US employees, human resources professionals, and chief executives, 55 percent of chief executives reported a mental health issue in the previous year, up 24 points year over year, and 81 percent agreed that companies view someone with a mental health issue as weak or a burden. The second number explains the first.
Sources · PwC 2025 Annual Corporate Directors Survey, 638 corporate directors, published October 2025.
Reference line: PwC and The Conference Board Board Effectiveness Survey, more than 500 executives, published June 2025.
A standard employee assistance program does not close this. It was built for high-volume, short-term support across a whole workforce, and no chief executive routes something this sensitive through a channel the company administers. The reasoning is set out in our note on why executives do not use your EAP.
What chief executives actually bring to the work.
The presenting issues behind the board report, in the language of the role. Boards that want the earlier signals will find them in our note on the signs a leadership team is burned out.
Performing for the room
Every board meeting is an evaluation run by people who can remove you, however constructive the tone. The permission to be uncertain out loud disappears, and sustained assessment is where high-stakes anxiety takes hold.
No peer in the building
The chief executive cannot confide in a direct report, in a board that votes on their tenure, or in an investor. Every hard call is absorbed alone, the exact pattern leadership isolation therapy was built for.
The competence question
Strong chief executives rarely feel like the obvious choice from the inside. The gap between how the board sees them and how they see themselves widens, and imposter syndrome is common at exactly this altitude.
The volume of consequential calls
The role concentrates the decisions nobody else can make, with no reduction anywhere else in the week. Decision fatigue degrades judgment long before it shows up in the numbers.
Running hot for years
Sustained overwork at the top is read as commitment, which is why it goes uncorrected for so long. Executive burnout therapy exists to catch the pattern in the year it starts rather than the year it becomes a resignation.
The mind that will not stop
Carrying an organization is an effective way to lose sleep. Chronic hyper-vigilance erodes the recovery decision quality depends on, and executive insomnia is often the first visible signal that a chief executive is past their limit.
A transition nobody has named
Many chief executives decide privately that they are near the end of their run, then hold that decision alone for a year or more. Structured support through a CEO transition turns a surprise into a planned handover.
What the job costs at home
Travel, visibility, and a mental load that does not pause land on a household that got no vote. Couples therapy is part of the network because the strain of the seat is frequently visible there first.
The board reviewed everything about how we governed. In eleven years nobody in that room asked me how I was, and I would not have answered honestly if they had.
Session formats built for a board calendar.
Three lengths, no rigid weekly slot.
The steady cadence of ongoing therapy. Most clients spend most of their care in 50-minute sessions.
For work that needs more room than a standard hour can hold. See 90-minute sessions.
For work that needs uninterrupted time to reach resolution. See 3-hour therapy intensives.
Care is delivered in 50-minute, 90-minute, and 3-hour sessions by secure telehealth, nationwide. A chief executive moving through board meetings, investor days, and site visits can do concentrated work in a single longer block rather than defending a standing weekly appointment that travel will break, and the longest format is used most often at the two pressure points a board would recognize, the weeks around a crisis and the quarter before a transition. Continuity is preserved because the leader keeps the same clinician throughout.
Put the chief executive's condition on the agenda.
A confidential conversation about a board-level benefit takes one call. Nothing about it touches the company health plan, and nothing about it reaches the board file.
Start a partnership conversationHow a chief executive is matched.
Every chief executive is matched by hand, not by an algorithm running against an intake form. Clinicians are selected for experience with high-responsibility roles, and the match is reviewed by CEREVITY's clinical leadership.
The eligible individual submits a confidential intake form covering presenting issues, modality preference, professional context, and scheduling parameters. Operated by CEREVITY directly, not by a broker.
Intake is reviewed by CEREVITY's clinical leadership against the network's active capacity, current licensure footprint, and modality availability. This is the step that does not exist in an EAP.
A specific clinician is matched to the chief executive, who receives the match with the clinician's profile, modality, and credentials, plus a direct online scheduling link.
Scheduling runs directly through CEREVITY infrastructure with no phone handoff. First sessions are typically scheduled within 5 to 10 business days of the match.
Care continues on the cadence the clinical work requires, in 50-minute, 90-minute, or 3-hour sessions, without an employer-imposed session cap.
Capability comparison for boards supporting a CEO.
An evaluation framework on the dimensions that matter when a board scopes a leadership-tier offering. All three models have a place; they are built for different populations, which is the argument for a board-level channel alongside the existing program rather than instead of it.
| Dimension | Typical EAP | Executive-tier platform | CEREVITY |
|---|---|---|---|
| Network model | Broker layer between employer and contractor roster | Single-vendor platform, W-2 or contracted pool | Independent clinical network with direct relationships |
| Clinician assignment | First contractor to reply with availability | Algorithmic matching on intake-form inputs | Clinical review by network leadership |
| Intake and scheduling | Phone handoff to the clinician's line | App-based intake and scheduling | Network-operated intake, direct online scheduling |
| Session formats | Standard 50-minute, capped session counts | Standard 45 to 50-minute sessions | 50-minute, 90-minute, and 3-hour formats, no cap |
| Clinical scope | Acute, broadly applicable concerns | Workforce-wide, executive tier as an upsell | Built around the presenting issues of chief executives |
| Modality fit | Generalist talk therapy | Generalist therapy with some specialty | CBT, DBT, psychodynamic, IFS, matched at intake |
| Reach | National via roster density | National telehealth, roster variance | All 50 states via telehealth |
| Payment model | Employer-sponsored, in network | Per-employee-per-month seat pricing | Private pay, out of network, partnership agreement |
| Board visibility | Aggregate, broker-mediated | Vendor dashboards with engagement metrics | Administrative reporting only |
| Right fit for | Workforce-wide acute support | Mid-tier ongoing care with an executive add-on | boards supporting a CEO, end to end |
If the board has delegated a formal evaluation to a committee, our notes on what to look for in a private therapy provider cover the procurement side, including clinical governance and what the agreement should specify.
What the board sees, and what it does not.
A chief executive will not use a channel that reports back to the people who can remove them. CEREVITY is built so that using it creates no visibility into the care, with no record the employer sees, no utilization reporting to the board or its committees, and no confirmation to anyone that a given leader has engaged at all.
- Confirmation that contracted services were provided to eligible individuals.
- Aggregate utilization at the partnership level, where contractually appropriate.
- Invoicing and eligibility reconciliation.
- Nothing tied to a specific named chief executive's clinical content.
- Whether a specific named chief executive has scheduled, attended, or engaged.
- What clinical issues are being addressed, or which clinician is assigned.
- Session notes, treatment plans, or diagnostic information.
- Any attendance detail at the individual level.
Clinicians are independent licensed professionals operating under their own licensure and the confidentiality and privacy obligations that attach to it. Protected health information is held within the clinical infrastructure, and the agreements governing it are defined in writing before the partnership goes live. Our notice of privacy practices and privacy policy are published in full.
Clinical records, session content, and individual engagement data sit inside the clinical platform. The administrative layer the partner interacts with is structurally separate from the clinical layer.
Eligibility lists are maintained on the partner side and confirmed at the point of intake. Administering eligibility does not require the partner to receive clinical information back.
A Business Associate Agreement is executed where the partnership structure requires it, and whether one applies is a determination made with counsel rather than assumed. The partnership agreement defines the administrative reporting scope in writing before anything goes live. See also our terms of service.
Leaders ask about downstream exposure before they will engage at all, and a sitting chief executive asks earlier than most. The question that comes up first is whether therapy shows up on a background check, which matters more than usual to someone whose next role carries a public filing.
What the first 30 days look like.
The hardest part of a board-level partnership is not the contract. It is the period between signature and the first chief executive in care.
A 60-minute kickoff with your team and CEREVITY's partnership lead. We confirm the partnership shape, the eligibility model, the administrative reporting scope, and the internal owner. The BAA, where applicable, is executed.
Your team provides the eligible-individual list. CEREVITY confirms it against the network and establishes the verification path at intake. Only eligibility confirmation flows forward.
CEREVITY provides a confidential, board-level comms template explaining the benefit, the privacy posture, and how to access intake. It is written to be received without stigma.
Eligible individuals begin intake on their own cadence. First sessions are typically scheduled within 5 to 10 business days. By day 30 the partnership is operational and a quarterly review cadence is in place.
The business case for the board.
Continuity in the chair, decision quality between meetings, and credibility in succession are the levers, and a board already owns all three. If you are sizing the commitment, our executive benefits benchmarking notes set out what comparable organizations provide at this tier.
Continuity in the chair
An unplanned chief executive departure resets strategy and consumes a year of board attention. Confidential clinical care is one of the few interventions that reaches the person least likely to ask for help, and the link between retention and mental health is where most of the return sits.
Decision quality between meetings
A board sees the chief executive for a handful of days a year and inherits the consequences of every day in between. Judgment and pace degrade measurably under chronic unmanaged strain. It also gives an executive wellness program a top that is not conspicuously exempt from it.
Credibility in succession and recruiting
Candidates for the chair ask what support exists at the top, and the honest answer is usually nothing beyond a coach with a reporting line into the board. Offering confidential clinical care through a dedicated CEO therapist practice signals that the board treats the seat as survivable.
Questions boards and nominating committees ask first.
What is board effectiveness?
Board effectiveness is the degree to which a board actually performs its governance role: whether it has the right composition and skills, whether it gets information good enough to decide on, whether the boardroom permits genuine challenge, and whether it oversees and supports the chief executive well. Most large organizations assess it annually through a structured self-review.
What does a board effectiveness review cover?
A typical review covers composition and skills mix, director tenure and independence, meeting cadence and the quality of board materials, committee performance, boardroom dynamics, the relationship with management, and succession planning. It rarely covers the condition of the chief executive, the single point of failure the rest of the agenda depends on. Boards close that gap by scoping a confidential channel for their executives.
Should boards support CEO mental health?
Yes, and the argument is governance rather than benevolence. The board is accountable for leadership continuity and for the quality of the decisions the chief executive makes between meetings, and both degrade under sustained unmanaged strain. Providing a confidential channel is consistent with the wider employer duty of care an organization already accepts for everyone else, applied to the one role that is usually left out of it.
How is CEO support kept confidential from the board?
The board authorizes and funds the arrangement; it does not administer it. Care is private pay, so no insurance claim is filed and nothing routes through the company health plan. CEREVITY provides no individual reporting, no utilization data, and no confirmation that a named leader has engaged. Sessions remain between the chief executive and the licensed clinician, who is bound by their own licensure confidentiality obligations. Our guide to finding a therapist for your CEO sets out how a board scopes this.
Is this coaching or therapy?
It is therapy, delivered by licensed clinicians, and it is deliberately distinct from executive coaching. Coaching addresses performance and frequently reports back to a sponsor, which in this case would be the board. Therapy is confidential clinical care with no stakeholder except the leader. The distinction is set out in our comparison of executive counseling and executive coaching.
Which leaders would the benefit cover?
Scope is defined in the partnership agreement. Most boards start with the chief executive, then extend to the executives who report into the chair and to named successors, and some include directors themselves. The benefit is deliberately narrow so it stays board-level. You can scope it in a first call through the get started page.
What does it cost the organization?
Structure is agreed in the partnership conversation and depends on how many leaders are covered and how wide the access is. CEREVITY is a private-pay network with transparent fees and no insurance-driven surprises in the accounting, which makes it straightforward for a compensation committee to approve. Rates are published on our pricing page.
How do we begin?
Start a partnership conversation using the form on this page, by phone at (562) 295-6650, or through the contact page. A member of CEREVITY's clinical leadership will follow up directly and confidentially.
Start a partnership conversation.
Tell us about the board and the leaders it oversees. CEREVITY's clinical leadership will follow up directly and confidentially.
Further reading and related partnerships.
Research, clinical writing, and the other places CEREVITY supports leaders.
Research and reports
For boards and committees
Clinical writing
A note on sources.
Board assessment figures are drawn from PwC's 2025 Annual Corporate Directors Survey, a survey of 638 corporate directors published in October 2025, in which 78 percent said their board's assessment process does not give a complete picture of board performance, 73 percent said their board conducts no individual director assessments, and 55 percent said at least one of their board colleagues should be replaced. The executive-side reading is from the fifth annual Board Effectiveness Survey run by PwC and The Conference Board, published in June 2025, in which 35 percent of more than 500 executives rated their board's performance as excellent or good and 93 percent said at least one director should be replaced. Chief executive mental health figures come from the 2024 State of Workplace Empathy study published by Businessolver, a survey of more than 3,000 US employees, human resources professionals, and chief executives fielded in March 2024, in which 55 percent of chief executives reported a mental health issue in the previous year, up 24 points year over year, and 81 percent agreed that companies view someone with a mental health issue as weak or a burden. Figures are reported as published and are not adjusted. The structural argument on this page draws on the firsthand experience of CEREVITY clinicians who work with chief executives and boards. Specific contractual scopes, including any Business Associate Agreement, are confirmed in writing before a partnership goes live. Additional CEREVITY research is collected in our knowledge base.